Skip to main content

Advertisement

Log in

Practical strategies for treating chronic migraine with medication overuse: case examples and role play demonstrations

  • Symposium
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Patients with chronic migraine headaches complicated by medication overuse (MO) present some of the most difficult treatment challenges for headache practitioners. Recent research has identified a variety of risk factors (including MO) that appear to be associated with the escalation of the frequency and severity of migraine headache. Management of such patients with medication overuse headaches (MOH) may become more problematic due to co-morbid psychiatric issues common with migraine patients and the patient’s reluctance to limit/eliminate “overused” abortive medications. Medication adherence becomes an important treatment concern. The present article will highlight treatment issues that must be considered in the assessment and treatment of patients with chronic migraine and MOH. Case examples will be offered to illustrate the process of the implementation of these strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Stewart WF, Lipton RB, Celentano DD et al (1992) Prevalence of migraine headache in the United States: relation to age, income, race, and other sociodemographic factors. JAMA 267:64–69

    Article  PubMed  CAS  Google Scholar 

  2. Lipton RB, Hamelsky SW, Stewart WF (2001) Epidemiology and impact of headache. In: Silberstein SD, Lipton RB, Dalessio DJ (eds) Wolff’s headaches and other head pain, 7th edn. Oxford University Press, Oxford, pp 85–107

    Google Scholar 

  3. Lipton RB, Hamelsky SW, Kolodner KB et al (2000) Migraine, quality of life, and depression: a population-based case-controlled study. Neurology 55:629–635

    PubMed  CAS  Google Scholar 

  4. VonKorff M, Stewart WF, Simon DJ et al (1998) Migraine and reduced work performance: a population-based diary study. Neurology 50:1741–1745

    CAS  Google Scholar 

  5. Hu HX, Markson LE, Lipton RB et al (1999) Burden of migraine in the United States: disability and economic costs. Arch Intern Med 159:813–818

    Article  PubMed  CAS  Google Scholar 

  6. Lipton RB, Bigal ME (2007) Ten lessons in the epidemiology of migraine. Headache 47(Suppl 1):S2–S9

    Article  PubMed  Google Scholar 

  7. Bigal ME, Serrano D, Scher A et al (2008) Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 48(Suppl 4):S3

    Google Scholar 

  8. Katsarava Z, Schneeweiss S, Kurth T et al (2004) Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 62:788–790

    PubMed  CAS  Google Scholar 

  9. Lipton RB, Buse D, Serrano D et al (2008) Differences in rates of common comorbid medical and psychiatric conditions in chronic and episodic migraine individuals. Headache 48(Suppl 4):S4

    Google Scholar 

  10. Ferrari A, Leone S, Vergoni AV et al (2007) Similarities and differences between chronic migraine and episodic migraine. Headache 47:65–72

    Article  PubMed  Google Scholar 

  11. Peterlin BL, Tietjen G, Meng S et al (2008) Post-traumatic stress disorder in episodic and chronic migraine. Headache 48:517–522

    Article  PubMed  Google Scholar 

  12. Rapoport A (2008) Medication overuse headache: awareness, detection, and treatment. CNS Drugs 22(12):995–1004

    Article  PubMed  Google Scholar 

  13. Cupini LM, Calabresi P (2005) Medication-overuse headache: pathophysiological insights. J Headache Pain 6:199–202

    Article  PubMed  Google Scholar 

  14. Diener HC, Limroth V (2004) Medication-overuse headache: a worldwide problem. Lancet 3:475–483

    Article  Google Scholar 

  15. Colas R, Munoz P, Temprano R et al (2004) Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 62:1338–1342

    PubMed  CAS  Google Scholar 

  16. International Classification of Disorders, Committee of the International Headache Society (2004) Classification and diagnostic criteria for headache disorders, cranial neuralgia, and facial pain. Cephalalgia 24(Suppl 1):1–150

    Google Scholar 

  17. Meskunas CA, Tepper SJ, Rapoport AM et al (2006) Medications associated with probable medication overuse headache reported in a tertiary care headache center reported over a 15-year period. Headache 46:766–772

    Article  PubMed  Google Scholar 

  18. Dodick D, Freitag F (2006) Evidence-based understanding of medication overuse headache: clinical implications. Headache 46(Suppl 4):S202–S211

    Article  PubMed  Google Scholar 

  19. Mathew NT, Kurman R, Perez F (1990) Drug-induced refractory headache-clinical features and management. Headache 30:634–638

    Article  PubMed  CAS  Google Scholar 

  20. Ward TN (2008) Drug-induced refractory headache. Headache 48:728–729

    Article  PubMed  Google Scholar 

  21. Mathew NT (1990) Drug-induced headache. Neurol Clin 8:903–912

    PubMed  CAS  Google Scholar 

  22. Lake AE (2006) Medication overuse headache: biobehavioral issues and solutions. Headache 46(Suppl 3):S88–S97

    Article  PubMed  Google Scholar 

  23. Holroyd KA, O’Donnell FJ, Stensland M et al (2001) Management of chronic tension-type headache with tricyclic antidepressant medication, stress-management therapy, and their combination: a randomized controlled trial. JAMA 285:2208–2215

    Article  PubMed  CAS  Google Scholar 

  24. Grazzi L, Andrasik F, D’Amico D et al (2002) Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at three years. Headache 42:483–490

    Article  PubMed  Google Scholar 

  25. Rains JC, Lipchik GL, Penzien DB (2006) Behavioral facilitation of medical treatment for headache—part I: review of headache treatment compliance. Headache 46:1387–1394

    PubMed  Google Scholar 

  26. Rains JC, Penzien DB, Lipchik GL (2006) Behavioral facilitation of medical treatment for headache—part II: theoretical models and behavioral strategies for improving adherence. Headache 46:1395–1403

    PubMed  Google Scholar 

  27. Bigal ME, Lipton RB (2006) Modifiable risk factors for migraine progression. Headache 46:1334–1343

    Article  PubMed  Google Scholar 

  28. Lipton RB, Bigal ME, Diamond M et al (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68:343–349

    Article  PubMed  CAS  Google Scholar 

  29. Nicholson R, Bigal M (2008) Screening and behavioral management: obesity and weight management. Headache 48:51–57

    PubMed  Google Scholar 

  30. Bigal ME, Serrano D, Buse D et al (2008) Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 48:1157–1168

    Article  PubMed  Google Scholar 

  31. Wilkinson SM, Becker WJ, Heine JA (2001) Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache 41:303–309

    Article  PubMed  CAS  Google Scholar 

  32. Bahra A, Walsh M, Menon S et al (2003) Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 43:179–190

    Article  PubMed  Google Scholar 

  33. Paemeleire K, Bahra A, Evers S et al (2006) Medication-overuse headache in patients with cluster headache. Neurology 67:109–113

    Article  PubMed  CAS  Google Scholar 

  34. Rozen TD (2008) Migraine prevention: what patients want from medication and their physician. Headache 48:750–753

    Article  Google Scholar 

  35. Spierings EL, Miree LF (1993) Non-compliance with follow-up and improvement after treatment at a headache center. Headache 33:205–209

    Article  PubMed  CAS  Google Scholar 

  36. Holroyd KA, Cordingley GE, Pingel JD et al (1989) Enhancing the effectiveness of abortive therapy: a controlled evaluation of self management training. Headache 29:148–153

    Article  PubMed  CAS  Google Scholar 

  37. Gallagher RM, Kunkel R (2003) Migraine medication attributes important for patient compliance: concerns about side effects could delay treatment. Headache 43:36–43

    Article  PubMed  Google Scholar 

  38. Mulleners WM, Whitmarsh TE, Steiner TJ (1998) Noncompliance may render migraine prophylaxis useless, but once-daily regimens are better. Cephalalgia 18:52–56

    Article  PubMed  CAS  Google Scholar 

  39. Packard RC, Brown F (1986) Multiple headaches in a case of multiple personality disorder. Headache 26:99–102

    Article  PubMed  CAS  Google Scholar 

  40. Ng-Mak DS, Cady R, Chen Y et al (2007) Can migraineurs accurately identify their headaches as “migraine” at attack onset? Headache 47:645–653

    Article  PubMed  Google Scholar 

  41. Golden W, Katic BJ, Hu H (2008) Factors associated with early treatment of acute migraine headache pain. Headache 48(Suppl):S42–S43

    Google Scholar 

  42. Golden W, Katic BJ, Hu H (2008) Why did migraine patients not treat migraine attacks as early as they desired? Headache 48(Suppl):S42

    Google Scholar 

  43. Hamelsky SW, Lipton RB (2006) Psychiatric comorbidity of migraine. Headache 46:1327–1333

    PubMed  Google Scholar 

  44. Low NCD, Merikangas KR (2003) The comorbidity of migraine. CNS Spectr 8:433–444

    PubMed  Google Scholar 

  45. Breslau N, Lipton RB, Stewart WF et al (2003) Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology 60:1308–1312

    PubMed  CAS  Google Scholar 

Download references

Conflict of interest statement

I certify that there is no actual or potential conflict of interest in relation to this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Randall E. Weeks.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weeks, R.E. Practical strategies for treating chronic migraine with medication overuse: case examples and role play demonstrations. Neurol Sci 30 (Suppl 1), 95–99 (2009). https://doi.org/10.1007/s10072-009-0080-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-009-0080-4

Keywords

Navigation